Hyperalimentation bei Krebspatienten

  • E. M. CopelandIII
Conference paper

Zusammenfassung

Die intravenöse Hyperalimentation (IVH) wurde vor 1972 vor allem aus zwei Gründen nicht in großem Umfang bei Krebspatienten eingesetzt:
  1. 1.

    Es bestand der Verdacht, daß das Tumorwachstum durch den hohen Kaloriengehalt der Nährlösungen stimuliert würde.

     
  2. 2.

    Man fürchtete septische Komplikationen durch den für die IVH unerlässlichen zentralen Venenkatheter. Insbesondere Tumorpatienten schienen hierbei besonders gefährdet, da durch die Chemo- oder Radiotherapie ihre Leukozytenzahl ohnehin bereits vermindert und ihr Immunstatus als Sekundärfolge der onkologischen Therapie oder einer bereits vorher bestehenden Mangelernährung beeinträchtigt war.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Brennan MF (1977) Uncomplicated starvation versus cancer cachexia. Cancer Res 37: 2359–2364PubMedGoogle Scholar
  2. 2.
    Cameron IL, Pavlat WA (1976) Stimulation of growth of a transplantable hepatoma in rats by parenteral nutrition. J Natl Cancer Inst 56:597–602PubMedGoogle Scholar
  3. 3.
    Copeland EM, Dudrick SJ (1976) Nutritional aspects of cancer. In: Hickey RC (ed) Current problems in cancer. Year Book Medical, Chicago, pp 1–51Google Scholar
  4. 4.
    Copeland EM, MacFadyen BV Jr, McGrown C, Dudrick SJ (1974) The use of hyperalimentation in patients with potential sepsis. Surg Gynecol Obstet 138:377–380PubMedGoogle Scholar
  5. 5.
    Copeland EM, MacFadyen BV, Lanzotti V, Dudrick SJ (1975) Intravenous hyperalimentation as an adjunct to cancer chemotherapy. Am J Surg 129:167–173PubMedCrossRefGoogle Scholar
  6. 6.
    Daly JM, Reynolds HM, Rowlands BJ, Baquero GE, Dudrick SJ, Copeland EM (1978) Nutritional manipulation of tumor-bearing animals: Effects on body weight, serum protein levels, and tumor growth. Surg Forum 29:143–144PubMedGoogle Scholar
  7. 7.
    Daly JM, Copeland EM, Dudrick SJ (1978) Effects of intravenous nutrition on tumor growth and host immunocompetence in malnourished animals. Surgery 84:655–658PubMedGoogle Scholar
  8. 8.
    Daly JM, Dudrick SJ, Copeland EM (1978) Effects of protein depletion and repletion on cell-mediated immunity in experimental animals. Ann Surg 188:791–796PubMedCrossRefGoogle Scholar
  9. 9.
    Daly JM, Copeland EM, Dudrick SJ, Delaney JM (to be published) Nutritional repletion of malnourished tumor-bearing and non tumor bearing rats: Effects on body weight, liver, muscle and tumor. J Surg ResGoogle Scholar
  10. 10.
    Dionigi R, Guaglio R, Bonera A, Cerri M, Rondanelli R, Campani M (1976) Clinical-pharmacological aspects, application and effectiveness of total parenteral nutrition in surgical patients. Int J Clin Pharmacol Biopharm 17:107–118Google Scholar
  11. 11.
    Eys J van (1979) Malnutrition in children with cancer: Incidence and consequence. Cancer 43:2030–2035PubMedCrossRefGoogle Scholar
  12. 12.
    Filler RM, Jaffe N, Cassady JR, Traggis DG, Das JB (1977) Parenteral nutritional support in children with cancer. Cancer 39:2665–2669PubMedCrossRefGoogle Scholar
  13. 13.
    Floyd C, Ota D, Corriere JN, Dudrick SJ, Copeland EM (1979) Effect of protein depletion on serum factors for lymphocyte transformation. Surg Forum 30:57–60PubMedGoogle Scholar
  14. 14.
    Haffejee AA, Angorn IB (1979) Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma. Ann Surg 189:475–479PubMedGoogle Scholar
  15. 15.
    Harvey KB, Bothe A, Blackburn GL (1979) Nutritional assessment and patient outcome during oncologic therapy. Cancer 43:2065–2069Google Scholar
  16. 16.
    Issell BF, Valdivieso M, Zaren HA, Dudrick SJ, Freireich EJ, Copeland EM, Bodey GP (1978) Protection against chemotherapy toxicity by IV hyperalimentation. Cancer Treat Rep 62:1139–1143PubMedGoogle Scholar
  17. 17.
    Lanzotti VC, Copeland EM, George SL, Dudrick SJ, Samuels ML (1975) Cancer chemo-therapeutic response and intravenous hyperalimentation. Cancer Treat Rep 59:437–439Google Scholar
  18. 18.
    Reynolds HM, Daly JM, Rowlands BJ, Dudrick SJ, Copeland EM (to be published) Effects of nutritional repletion on host and tumor response to chemotherapy. CancerGoogle Scholar
  19. 19.
    Rickard KA, Grosfeld JL, Kirksey A, Valentine TVN, Baehner RL (1979) Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease. Ann Surg 190:771–781PubMedCrossRefGoogle Scholar
  20. 20.
    Seniukov MV, Khmelevskii IM, Zubov OG, Sloventantor VI, Kaplan NA (1978) Parenteral feeding of patients with cancer of the larynx undergoing combination therapy. Vestn Otori-nolaringol 2:66–72Google Scholar
  21. 21.
    Solassol C, Joyeux H (to be published) Artificial gut with complete nutritive mixtures as a major adjuvant therapy in cancer patient’s treatment. Proceedings of the International Society of Parenteral Nutrition, Rio de Janiero, Brazil, August 28, 1978. Acta Chir ScandGoogle Scholar
  22. 22.
    Steiger E, Oram-Smith J, Miller E, Kuo L, Voss HM (1975) Effects of nutrition on tumor growth and tolerance to chemotherapy. J Surg Res 18:455–461PubMedCrossRefGoogle Scholar
  23. 23.
    Theologides A (1979) Cancer cachexia. Cancer 43:2004–2012Google Scholar
  24. 24.
    Wilmore DW, Dudrick SJ (1969) Safe long-term venous catheterization. Arch Surg 98: 256–258PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • E. M. CopelandIII
    • 1
  1. 1.The University of TexasUSA

Personalised recommendations